Skip to main content

Greenberg Traurig’s David J. Dykeman and Roman Fayerberg to Present at DeviceTalks Boston

BOSTON – April 21, 2025 – David J. Dykeman, co-chair of the Life Sciences & Medical Technology Practice of global law firm Greenberg Traurig, LLP, and Roman Fayerberg, co-chair of the Boston office’s Intellectual Property (IP) & Technology Practice, will present on the DeviceTalks Boston panel, “Positioning IP for Funding & Exits,” April 30, from 11:30 a.m. - 12:15 p.m. EDT.

The session will focus on best practices and pitfalls to avoid in building strategic patent portfolios to close funding, stay competitive, and secure an exit. Panelists will also discuss how to position a medtech company to attract investors, collaborators, and partners. Dykeman and Fayerberg will be joined by Jonathan Black, partner at Bluwave Capital, and Irina Ridley, chief legal officer at Aerin Medical.

Boston office Co-Managing Shareholder Dykeman is a registered patent attorney with over 25 years of experience in patent and IP law. He focuses his practice on securing worldwide IP protection and related business strategy for high-tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. He provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multinational corporations, and startup companies. He serves on the board of directors of MassMEDIC and was named “Massachusetts Patent Strategy Attorney of the Year” by LMG Life Sciences in 2022.

Fayerberg is a registered patent attorney with broad experience helping clients strategically protect and leverage their innovations globally. He works with clients to develop and manage worldwide patent portfolios and counsels clients regarding freedom to operate, patent landscape, and patent infringement and validity matters. Fayerberg also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities. He has represented clients ranging from startups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology.